Total Payments
$693.34
2024 Payments
$345.18
Companies
8
Transactions
23
Medicare Patients
4,810
Medicare Billing
$443,770
Payment Breakdown by Category
Food & Beverage$693.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $693.34 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $226.74 | 11 | $0 (2024) |
| NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. | $150.00 | 1 | $0 (2024) |
| ABBVIE INC. | $122.55 | 1 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $108.24 | 6 | $0 (2024) |
| Novo Nordisk Inc | $50.00 | 1 | $0 (2021) |
| Allergan Inc. | $13.22 | 1 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $11.39 | 1 | $0 (2020) |
| Lilly USA, LLC | $11.20 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $345.18 | 8 | NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. ($150.00) |
| 2022 | $122.55 | 1 | ABBVIE INC. ($122.55) |
| 2021 | $50.00 | 1 | Novo Nordisk Inc ($50.00) |
| 2020 | $11.39 | 1 | Supernus Pharmaceuticals, Inc. ($11.39) |
| 2019 | $39.11 | 3 | AstraZeneca Pharmaceuticals LP ($27.91) |
| 2018 | $71.05 | 5 | AstraZeneca Pharmaceuticals LP ($57.83) |
| 2017 | $54.06 | 4 | AstraZeneca Pharmaceuticals LP ($54.06) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $86.94 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardio-renal | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardio-renal | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardio-renal | ||||||
| 03/19/2024 | NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. | Hera W10 (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: Ultrasound | ||||||
| 02/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardio-renal | ||||||
| 08/30/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Diabetes | ||||||
| 04/27/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.39 | General |
| Category: AED | ||||||
| 04/15/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Neuroscience | ||||||
| 03/08/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2019 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,143 | 2,216 | $557,331 | $101,770 |
| 2022 | 11 | 995 | 2,146 | $509,108 | $93,528 |
| 2021 | 12 | 1,261 | 2,476 | $304,958 | $125,028 |
| 2020 | 9 | 1,411 | 2,543 | $288,812 | $123,444 |
Total Patients
4,810
Total Services
9,381
Medicare Billing
$443,770
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 327 | $147,150 | $30,208 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 256 | 256 | $116,736 | $20,700 | 17.7% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 20 | 37 | $95,923 | $20,526 | 21.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 164 | 240 | $96,926 | $12,965 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 123 | $36,408 | $8,286 | 22.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 121 | 121 | $36,784 | $5,916 | 16.1% |
| 29075 | Application of elbow to finger cast | Office | 2023 | 12 | 15 | $7,185 | $1,039 | 14.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 173 | 1,058 | $13,580 | $824.21 | 6.1% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 11 | 11 | $2,717 | $514.80 | 18.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $2,002 | $493.79 | 24.7% |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | Office | 2023 | 14 | 17 | $1,921 | $297.05 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 284 | $127,800 | $25,799 | 20.2% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2022 | 29 | 40 | $103,700 | $23,932 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 177 | 177 | $80,712 | $14,558 | 18.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 165 | 240 | $99,246 | $13,424 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 84 | $24,864 | $5,288 | 21.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 76 | 76 | $23,104 | $3,926 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $23,331 | $3,764 | 16.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 181 | 1,166 | $15,324 | $975.69 | 6.4% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2022 | 12 | 18 | $4,644 | $739.90 | 15.9% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 14 | 16 | $4,199 | $647.64 | 15.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $2,184 | $473.97 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 289 | 383 | $52,878 | $36,504 | 69.0% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2021 | 27 | 45 | $146,793 | $27,179 | 18.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 138 | 138 | $25,485 | $16,993 | 66.7% |
About Dr. Daniel Montero, MD
Dr. Daniel Montero, MD is a Sports Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841264736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Montero, MD has received a total of $693.34 in payments from pharmaceutical and medical device companies, with $345.18 received in 2024. These payments were reported across 23 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($693.34).
As a Medicare-enrolled provider, Montero has provided services to 4,810 Medicare beneficiaries, totaling 9,381 services with total Medicare billing of $443,770. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Jacksonville, FL
- Active Since 02/15/2006
- Last Updated 08/31/2020
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1841264736
Products in Payments
- Hera W10 (Device) $150.00
- QULIPTA (Drug) $122.55
- Kerendia (Drug) $108.24
- FARXIGA (Drug) $97.97
- AIRSUPRA (Drug) $86.94
- RYBELSUS (Drug) $50.00
- BYDUREON (Drug) $41.83
- VIBERZI (Drug) $13.22
- TROKENDI XR (Drug) $11.39
- EMGALITY (Drug) $11.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Jacksonville
Zachary Rogozinski, M.d, M.D
Sports Medicine — Payments: $60,367
Sports Medicine $60,367
Dr. Om Kapoor, Md, MD
Sports Medicine — Payments: $48,702
Sports Medicine $48,702
Johnny Washington, Md, MD
Sports Medicine — Payments: $14,495
Sports Medicine $14,495
Dr. Georges El Bahri, M.d, M.D
Sports Medicine — Payments: $9,279
Sports Medicine $9,279
Kevin Murphy, Md, MD
Sports Medicine — Payments: $6,969
Sports Medicine $6,969
Scott Marberry, Md, MD
Sports Medicine — Payments: $5,544
Sports Medicine $5,544